CollPlant Biotechnologies Ltd has filed a Form D, indicating an exempt offering of securities. This filing, submitted on October 22, 2026, is significant as it reflects the company's ongoing financial strategies and efforts to secure funding.
Background
CollPlant Biotechnologies Ltd operates in the orthopedic, prosthetic, and surgical appliances and supplies sector, classified under SIC code 3842. The company is listed on the Nasdaq under the ticker symbol CLGN. Recent filings include a Form 3 on October 19, 2026, and a Form 6-K on October 15, 2026.
What the Filing Says
The filing includes details regarding the offering of securities under Item 06b. However, specific terms or amounts related to this offering were not disclosed in the filing.
Impact
This filing may affect investors and stakeholders looking for insights into CollPlant's financial health and strategic direction. Additionally, competitors in the orthopedic and surgical supplies industry might closely monitor this development as it could indicate shifts in market dynamics.
What's Next
The filing does not say what happens next.
Company Information
CollPlant Biotechnologies Ltd is incorporated in L3 and has a fiscal year ending on December 31. The company’s Central Index Key (CIK) is 0001631487, which can be used to access all its filings with the SEC.
Contact Information
The mailing and business address for CollPlant is 4 Oppenheimer St., 11th Floor, Rehovot, L3 74140, Israel. For inquiries, the company can be reached at the phone number 972-73-232-5600.
Regulatory Details
This filing is categorized under the Securities Act of 1933, specifically under Act 33, and is designated as Type D. The file number associated with this offering is 021-602262.
Additional Context
While the filing provides details on the exempt offering, it does not specify the total amount of securities being offered or any specific terms related to the offering. This lack of detail may leave potential investors seeking more comprehensive information to make informed decisions.